Skip to content

Monarch Robotic Bronchoscopy for Lung Nodule ICG Dye Marking Before VATS

Effectiveness, Safety and Learning Curve of Monarch Robotic Assisted Bronchoscopy for Lung Nodule ICG Dye Marking Before VATS Sublobectomy

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07177924
Acronym
REALM
Enrollment
50
Registered
2025-09-17
Start date
2025-10-10
Completion date
2026-05-30
Last updated
2025-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer (Suspected or Confirmed), Pulmonary Nodule Localization, Small Pulmonary Nodules, Video-assisted Thoracoscopic Surgery (VATS)

Keywords

Robotic Assisted Bronchoscopy, Monarch Platform, Lung Nodule Localization, Video-Assisted Thoracoscopic Surgery (VATS), Pulmonary Nodules, Lung Cancer Surgery

Brief summary

This is a single-center, prospective, single-arm clinical study conducted at Beijing Cancer Hospital to evaluate the effectiveness, safety, and learning curve of preoperative indocyanine green (ICG) dye marking mixed with iodinated contrast agent under Monarch Robotic Assisted Bronchoscopy (RAB) with Cone-Beam CT (CBCT) for small pulmonary nodules that are difficult to locate during video-assisted thoracic surgery (VATS) sublobectomy. Eligible patients will undergo RAB localization immediately followed by VATS in the same operative session. The primary endpoints include the success rate of localization, effective localization, and VATS sublobar resection. Secondary endpoints include navigation success rate, operation times, reaching depth, complication rates, and health economic outcomes. The learning curve will be analyzed using the cumulative sum (CUSUM) method. A total of 50 patients will be enrolled and followed up for 14 days postoperatively.

Interventions

PROCEDUREMonarch RAB with CBCT-guided ICG Dye Marking

Under general anesthesia, the Monarch RAB platform is used to navigate to the target bronchus. With CBCT confirmation, 0.25 ml of ICG (0.2 mg/ml) mixed with 0.25 ml iodinated contrast is injected within 1 cm of the nodule. The dye marking is identified intraoperatively with near-infrared light to guide VATS sublobectomy.

Sponsors

Peking University Cancer Hospital & Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Single-center, prospective, single-arm interventional study in which all enrolled patients with small pulmonary nodules difficult to localize during VATS will undergo preoperative indocyanine green (ICG) mixed with iodinated contrast dye marking under Monarch Robotic Assisted Bronchoscopy (RAB) with Cone-Beam CT (CBCT) guidance, immediately followed by VATS sublobectomy in the same operative session. The localization procedure is performed by a single surgeon without prior RAB localization experience to evaluate the learning curve.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-80 years * Clinically indicated sub-lobar resection * Tolerates general anesthesia * Single/multiple small nodules \<20 mm in peripheral lung field * Nodules difficult to locate intraoperatively by inspection/palpation

Exclusion criteria

* Contraindications to bronchoscopy/anesthesia * Coagulopathy or bleeding tendency * Implanted devices interfering with navigation * Allergy to ICG or iodinated contrast * Pregnant/lactating women * Intraoperative findings not suitable for procedure

Design outcomes

Primary

MeasureTime frameDescription
Success rate of localization procedurePeriprocedural( localization procedure)Calculated as (number of successful localization procedures ÷ total localization procedures) × 100%. Success is defined as ICG dye successfully injected at planned target site as confirmed by CBCT. Unit of Measure: participants (%).
Success rate of effective localizationPerioperative (during VATS)Calculated as \[(number of successful localization procedures - number unrecognized in operative field) ÷ total localization procedures\] × 100%. Effective localization is defined as visible ICG staining on pleura during VATS. Unit of Measure: participants (%).
Success rate of VATS sub-lobar resectionPerioperative (during VATS)Calculated as (number of successful VATS resections ÷ total localization procedures) × 100%. Successful VATS resection is defined as resection containing the complete lesion and the dye together. Unit of Measure: participants (%).

Secondary

MeasureTime frameDescription
Learning curve for localizationThrough study completion, up to 8 monthsNumber of cases required for surgeon to achieve proficiency using cumulative sum (CUSUM) method based on OT1 and localization success rate.Unit of Measure: case number.
Bronchoscopy-related complication rateFrom end of bronchoscopy through Postoperative Day 14.Incidence of pneumothorax, bleeding, and respiratory failure related to bronchoscopy, graded according to CTCAE. participants (%).
Health economic outcomesDuring index hospitalizationIncludes postoperative hospital stay, total hospitalization cost, complication treatment cost, anesthesia cost, and localization procedure cost. Unit of Measure: CNY.

Contacts

Primary ContactBingyang Huang
bingyanghuang@outlook.com+8613161541915

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026